IP Library Patent Application 18741321
Patent Application
App. No. 18/741,321

MODULATION OF TARGETED NERVE FIBERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/741,321
Abstract

According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves within a wall of (e.g., within adventitia surrounding a lumen of) an artery or other blood vessel, such as the common hepatic artery.

Claims (33)

1 . A neuromodulation system comprising:

a catheter including an expandable element at a distal portion of the catheter and a therapeutic element within the expandable element, the therapeutic element configured to deliver energy to one or more nerves proximate a blood vessel; and

a processor configured to:

control a pump to deliver a fluid to the expandable element to expand the expandable element against a vessel wall of the blood vessel, and

control the pump to circulate the fluid within the expandable element during a period of energy delivery by the therapeutic element at a flow rate that is based on an indication of temperature.

2 . The system of claim 1 , wherein a range of drive pressures within the expandable member to provide the flow rate is 25 psi to 150 psi.

3 . The system of claim 1 , wherein the therapeutic element comprises an ultrasound transducer, and wherein the energy comprises ultrasound energy sufficient to ablate nerves surrounding the blood vessel.

4 . The system of claim 1 , wherein expandable element is configured to occlude the blood vessel to restrict blood flow through the blood vessel.

5 . The system of claim 1 , wherein circulation of the fluid through the expandable element cools the vessel wall.

6 . The system of claim 1 ,

wherein the catheter includes an inlet lumen and an outlet lumen, and

wherein the pump is configured to deliver the fluid to the expandable element through the inlet lumen and remove the fluid from the expandable element through the outlet lumen.

7 . The system of claim 1 , wherein the processing is configured to control the pump to maintain a constant flow rate of the fluid through the expandable element.

8 . The system of claim 1 , wherein the pump is configured to continuously circulate the fluid through the expandable element during delivery of energy by the therapeutic element.

9 . The system of claim 1 , wherein the processor is configured to control delivery of the energy via the therapeutic element according to a preconfigured energy profile.

10 . The system of claim 1 , wherein the processor is configured to control delivery of energy via the therapeutic element to heat the one or more nerves proximate the blood vessel to a temperature of 50 degrees Celsius to 90 degrees Celsius.

11 . The system of claim 1 , wherein a time duration of delivery of energy by the therapeutic element is 1 second to 120 seconds.

12 . The system of claim 1 , wherein the processor is configured to determine the flow rate based on the indication of temperature.

13 . The system of claim 1 , wherein the fluid is saline or water.

14 . A neuromodulation system comprising:

a catheter including an expandable element at a distal portion of the catheter and a therapeutic element within the expandable element, the therapeutic element configured to deliver energy to one or more nerves proximate a blood vessel; and

a processor configured to:

control a pump to deliver a fluid within the expandable element to expand the expandable element against a vessel wall of the blood vessel, and

control the pump to circulate the fluid within the expandable element during a period of energy delivery at a constant flow rate by adjusting a drive pressure provided to the fluid.

15 . The system of claim 14 , wherein a range of drive pressures within the expandable member to provide the constant flow rate is 25 psi to 150 psi.

16 . The system of claim 14 , wherein circulation of the fluid through the expandable element cools the vessel wall.

17 . The system of claim 14 , wherein the pump is configured to continuously circulate the fluid through the expandable element during delivery of energy by the therapeutic element.

18 . The system of claim 14 , further comprising a processor configured to control delivery of the energy via the therapeutic element according to a preconfigured energy profile.

19 . The system of claim 18 , wherein the processor is configured to control delivery of energy via the therapeutic element to heat the nerves surrounding the blood vessel to a temperature of 50 degrees Celsius to 90 degrees Celsius.

20 . A method comprising:

delivering, by a therapeutic element of a catheter including an expandable element at a distal portion of the catheter, energy to one or more nerves proximate a blood vessel;

controlling, by a processor, a pump to deliver a fluid to the expandable element to expand the expandable element against a vessel wall of the blood vessel; and

controlling, by the processor, the pump to circulate the fluid within the expandable element during a period of energy delivery by the therapeutic element at a flow rate that is based on an indication of temperature.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2024
From: AZAMIAN, BOBAK ROBERT; COE, JONATHAN ALLEN; VAFAI, SCOTT BRADLEY
To: METAVENTION, INC.
Reel/Frame 067709/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2024
From: METAVENTION, INC.
To: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
Reel/Frame 067709/0922 →